Company page

First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc. is a public company traded under the ticker TRAX in the American market. The company has a market capitalization of approximately $615.5 million. First Tracks focuses on developing innovative biotherapeutic solutions.